Respiratory morbidity among patients with pulmonary TB who have undergone cat I therapy under revised national tuberculosis control programme

dc.contributor.guide	Sudheendra Ghosh, C
dc.coverage.spatial	Medicine
dc.creator.researcher	Ronald Win, B
dc.date.accessioned	2022-10-21T09:19:56Z
dc.date.available	2022-10-21T09:19:56Z
dc.date.awarded	n.d.
dc.date.completed	2017
dc.date.registered	n.d.
dc.description.abstract	newline Abstract available
dc.description.note	Bibliography p. 142-150, Appendix given
dc.format.accompanyingmaterial	None
dc.format.dimensions
dc.format.extent	150p.
dc.identifier.uri	http://hdl.handle.net/10603/414078
dc.language	English
dc.publisher.institution	Faculty of Medicine
dc.publisher.place	Thiruvananthapuram
dc.publisher.university	University of Kerala
dc.relation	No. of references 83
dc.rights	university
dc.source.university	University
dc.subject.keyword	Acute Immuno Deficiency Syndrome
dc.subject.keyword	Bacili Calmettee Guerin
dc.subject.keyword	Clinical Medicine
dc.subject.keyword	Clinical Pre Clinical and Health
dc.subject.keyword	Human Immunodeficiency Virus
dc.subject.keyword	Medical Ethics
dc.subject.keyword	Para Amino Salizylic Acid
dc.subject.keyword	Tuberculosis
dc.subject.keyword	Tumour Necrosis Factor
dc.title	Respiratory morbidity among patients with pulmonary TB who have undergone cat I therapy under revised national tuberculosis control programme
dc.title.alternative
dc.type.degree	Ph.D.